291 related articles for article (PubMed ID: 33297435)
1. Getting Lost in the Cell-Lysosomal Entrapment of Chemotherapeutics.
Zhai X; El Hiani Y
Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33297435
[TBL] [Abstract][Full Text] [Related]
2. Lysosomes as mediators of drug resistance in cancer.
Zhitomirsky B; Assaraf YG
Drug Resist Updat; 2016 Jan; 24():23-33. PubMed ID: 26830313
[TBL] [Abstract][Full Text] [Related]
3. Targeting Lysosomes: A Strategy Against Chemoresistance in Cancer.
Shirbhate E; Singh V; Mishra A; Jahoriya V; Veerasamy R; Tiwari AK; Rajak H
Mini Rev Med Chem; 2024 Feb; ():. PubMed ID: 38343053
[TBL] [Abstract][Full Text] [Related]
4. Influence of lysosomal sequestration on multidrug resistance in cancer cells.
Halaby R
Cancer Drug Resist; 2019; 2(1):31-42. PubMed ID: 35582144
[TBL] [Abstract][Full Text] [Related]
5. Lysosomal sequestration of hydrophobic weak base chemotherapeutics triggers lysosomal biogenesis and lysosome-dependent cancer multidrug resistance.
Zhitomirsky B; Assaraf YG
Oncotarget; 2015 Jan; 6(2):1143-56. PubMed ID: 25544758
[TBL] [Abstract][Full Text] [Related]
6. Drug Sequestration in Lysosomes as One of the Mechanisms of Chemoresistance of Cancer Cells and the Possibilities of Its Inhibition.
Hraběta J; Belhajová M; Šubrtová H; Merlos Rodrigo MA; Heger Z; Eckschlager T
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32575682
[TBL] [Abstract][Full Text] [Related]
7. Targeting Lysosomes in Cancer as Promising Strategy to Overcome Chemoresistance-A Mini Review.
Geisslinger F; Müller M; Vollmar AM; Bartel K
Front Oncol; 2020; 10():1156. PubMed ID: 32733810
[TBL] [Abstract][Full Text] [Related]
8. Lysosomal accumulation of anticancer drugs triggers lysosomal exocytosis.
Zhitomirsky B; Assaraf YG
Oncotarget; 2017 Jul; 8(28):45117-45132. PubMed ID: 28187461
[TBL] [Abstract][Full Text] [Related]
9. Typical and Atypical Inducers of Lysosomal Cell Death: A Promising Anticancer Strategy.
Domagala A; Fidyt K; Bobrowicz M; Stachura J; Szczygiel K; Firczuk M
Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30071644
[TBL] [Abstract][Full Text] [Related]
10. P-glycoprotein mediates drug resistance via a novel mechanism involving lysosomal sequestration.
Yamagishi T; Sahni S; Sharp DM; Arvind A; Jansson PJ; Richardson DR
J Biol Chem; 2013 Nov; 288(44):31761-71. PubMed ID: 24062304
[TBL] [Abstract][Full Text] [Related]
11. Targeting TPC2 sensitizes acute lymphoblastic leukemia cells to chemotherapeutics by impairing lysosomal function.
Geisslinger F; Müller M; Chao YK; Grimm C; Vollmar AM; Bartel K
Cell Death Dis; 2022 Aug; 13(8):668. PubMed ID: 35915060
[TBL] [Abstract][Full Text] [Related]
12. The role of endolysosomal trafficking in anticancer drug resistance.
Hussein NA; Malla S; Pasternak MA; Terrero D; Brown NG; Ashby CR; Assaraf YG; Chen ZS; Tiwari AK
Drug Resist Updat; 2021 Jul; 57():100769. PubMed ID: 34217999
[TBL] [Abstract][Full Text] [Related]
13. Imidazoacridinone-dependent lysosomal photodestruction: a pharmacological Trojan horse approach to eradicate multidrug-resistant cancers.
Adar Y; Stark M; Bram EE; Nowak-Sliwinska P; van den Bergh H; Szewczyk G; Sarna T; Skladanowski A; Griffioen AW; Assaraf YG
Cell Death Dis; 2012 Apr; 3(4):e293. PubMed ID: 22476101
[TBL] [Abstract][Full Text] [Related]
14. The Lysosomotropic Activity of Hydrophobic Weak Base Drugs is Mediated via Their Intercalation into the Lysosomal Membrane.
Stark M; Silva TFD; Levin G; Machuqueiro M; Assaraf YG
Cells; 2020 Apr; 9(5):. PubMed ID: 32349204
[TBL] [Abstract][Full Text] [Related]
15. Propranolol Sensitizes Vascular Sarcoma Cells to Doxorubicin by Altering Lysosomal Drug Sequestration and Drug Efflux.
Saha J; Kim JH; Amaya CN; Witcher C; Khammanivong A; Korpela DM; Brown DR; Taylor J; Bryan BA; Dickerson EB
Front Oncol; 2020; 10():614288. PubMed ID: 33598432
[TBL] [Abstract][Full Text] [Related]
16. Destination 'lysosome': a target organelle for tumour cell killing?
Castino R; Démoz M; Isidoro C
J Mol Recognit; 2003; 16(5):337-48. PubMed ID: 14523947
[TBL] [Abstract][Full Text] [Related]
17. Intrinsic fluorescence of the clinically approved multikinase inhibitor nintedanib reveals lysosomal sequestration as resistance mechanism in FGFR-driven lung cancer.
Englinger B; Kallus S; Senkiv J; Heilos D; Gabler L; van Schoonhoven S; Terenzi A; Moser P; Pirker C; Timelthaler G; Jäger W; Kowol CR; Heffeter P; Grusch M; Berger W
J Exp Clin Cancer Res; 2017 Sep; 36(1):122. PubMed ID: 28882160
[TBL] [Abstract][Full Text] [Related]
18. Lysosomal Exocytosis, Exosome Release and Secretory Autophagy: The Autophagic- and Endo-Lysosomal Systems Go Extracellular.
Buratta S; Tancini B; Sagini K; Delo F; Chiaradia E; Urbanelli L; Emiliani C
Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32276321
[TBL] [Abstract][Full Text] [Related]
19. Tumor stressors induce two mechanisms of intracellular P-glycoprotein-mediated resistance that are overcome by lysosomal-targeted thiosemicarbazones.
Al-Akra L; Bae DH; Sahni S; Huang MLH; Park KC; Lane DJR; Jansson PJ; Richardson DR
J Biol Chem; 2018 Mar; 293(10):3562-3587. PubMed ID: 29305422
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the endolysosomal system in human chordoma cell lines: is there a role of lysosomes in chemoresistance of this rare bone tumor?
Kolb-Lenz D; Fuchs R; Lohberger B; Heitzer E; Meditz K; Pernitsch D; Pritz E; Groselj-Strele A; Leithner A; Liegl-Atzwanger B; Rinner B
Histochem Cell Biol; 2018 Jul; 150(1):83-92. PubMed ID: 29725750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
